semaglutide patent expiration us Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Magic pill' moment? What happens

Medically reviewed by Patricia Hartke, Pharm.D., BCPS Last update: April 22, 2026 Est

You have no consumer protections

During periods of significant illness or dehydration, patients should seek medical advice and may need to temporarily interrupt treatment

But opportunities to optimize the GLP-1 manufacturing lifecycle are emerging rapidly, as researchers pioneer new technologies and rethink traditional processes to keep pace with demand

Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions

Food and Drug Administration (FDA) has approved semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA), to treat type 2 diabetes mellitus (T2DM) and obesity